Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.

Daigle TL, Wetsel WC, Caron MG.

Eur J Neurosci. 2011 Nov;34(9):1378-89. doi: 10.1111/j.1460-9568.2011.07874.x.

2.

Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants.

Corbillé AG, Valjent E, Marsicano G, Ledent C, Lutz B, Hervé D, Girault JA.

J Neurosci. 2007 Jun 27;27(26):6937-47.

3.

Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlágh B.

J Neurosci. 2005 Mar 16;25(11):2874-84.

4.

Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.

Martín AB, Fernandez-Espejo E, Ferrer B, Gorriti MA, Bilbao A, Navarro M, Rodriguez de Fonseca F, Moratalla R.

Neuropsychopharmacology. 2008 Jun;33(7):1667-79. Epub 2007 Oct 24.

5.

A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.

Urs NM, Daigle TL, Caron MG.

Neuropsychopharmacology. 2011 Feb;36(3):551-8. doi: 10.1038/npp.2010.186. Epub 2010 Oct 27.

6.
7.

3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.

Wiley JL, Selley DE, Wang P, Kottani R, Gadthula S, Mahadeven A.

J Pharmacol Exp Ther. 2012 Feb;340(2):433-44. doi: 10.1124/jpet.111.187815. Epub 2011 Nov 15.

8.

Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.

Khajehali E, Malone DT, Glass M, Sexton PM, Christopoulos A, Leach K.

Mol Pharmacol. 2015 Aug;88(2):368-79. doi: 10.1124/mol.115.099192. Epub 2015 Jun 4.

9.

Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.

André VM, Cepeda C, Cummings DM, Jocoy EL, Fisher YE, William Yang X, Levine MS.

Eur J Neurosci. 2010 Jan;31(1):14-28. doi: 10.1111/j.1460-9568.2009.07047.x. Epub 2009 Dec 21.

PMID:
20092552
10.

Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.

Liu Q, Bhat M, Bowen WD, Cheng J.

J Pharmacol Exp Ther. 2009 Dec;331(3):1062-70. doi: 10.1124/jpet.109.156216. Epub 2009 Sep 14.

11.

Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5.

Fieblinger T, Sebastianutto I, Alcacer C, Bimpisidis Z, Maslava N, Sandberg S, Engblom D, Cenci MA.

J Neurosci. 2014 Mar 26;34(13):4728-40. doi: 10.1523/JNEUROSCI.2702-13.2014.

12.

Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.

Laprairie RB, Bagher AM, Kelly ME, Dupré DJ, Denovan-Wright EM.

J Biol Chem. 2014 Sep 5;289(36):24845-62. doi: 10.1074/jbc.M114.557025. Epub 2014 Jul 18.

13.

Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.

Sarantis K, Matsokis N, Angelatou F.

Neuroscience. 2009 Nov 10;163(4):1135-45. doi: 10.1016/j.neuroscience.2009.07.056. Epub 2009 Jul 30.

PMID:
19647050
14.
15.

Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.

Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG.

Mol Pharmacol. 2004 Jan;65(1):121-9.

16.

Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum.

De Chiara V, Angelucci F, Rossi S, Musella A, Cavasinni F, Cantarella C, Mataluni G, Sacchetti L, Napolitano F, Castelli M, Caltagirone C, Bernardi G, Maccarrone M, Usiello A, Centonze D.

J Neurosci. 2010 Jun 16;30(24):8127-37. doi: 10.1523/JNEUROSCI.1683-10.2010.

17.

Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades.

Chen J, Rusnak M, Lombroso PJ, Sidhu A.

Eur J Neurosci. 2009 Jan;29(2):287-306. doi: 10.1111/j.1460-9568.2008.06590.x.

18.
19.

Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.

Janoyan JJ, Crim JL, Darmani NA.

Pharmacol Biochem Behav. 2002 Jan-Feb;71(1-2):155-62.

PMID:
11812518
20.

CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum.

Price DA, Owens WA, Gould GG, Frazer A, Roberts JL, Daws LC, Giuffrida A.

J Neurochem. 2007 Apr;101(2):389-96. Epub 2007 Jan 23.

Supplemental Content

Support Center